Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

Identification of novel mechanisms of angiogenesis inhibition by p53

FY 2008-09

Summary
In order for cancers to grow and become life threatening, new blood vessels must form to deliver oxygen and nutrients to tumour cells. The process of blood vessel formation, or angiogenesis, is an absolutely necessary step in tumour formation without which they cannot grow beyond a few millimeters. Consequently, understanding the molecular machinery responsible for angiogenesis is highly critical, as it is an ideal process to target with novel therapeutic agents. The p53 tumour suppressor is a gene that becomes non-functional in half of all human cancers due to mutations. Previous research by our laboratory has found that p53 is able to inhibit angiogenesis in normal cells by causing the secretion of factors that prevent the formation of blood vessels. My project will aim to identify novel angiogenesis inhibitors activated by p53 and understand how p53 directs normal cells to release these inhibitors by dissecting the proteins and biochemical pathways involved in this process. This will lead to a better understanding of how natural angiogenesis inhibitors are produced and how their production is subverted in cancer. Furthermore, the properties of these natural angiogenesis inhibitors allow them to be translated almost directly to clinical studies, and may as such lead to the development of novel therapeutic avenues for the treatment of cancer.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
184697
Name
Assadian Sarah
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Identification of novel mechanisms of angiogenesis inhibition by p53
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
2d-Dige; Angiogenesis; Cancer; Collagen Synthesis; Collagen-Derived Antiangiogenic Factors; Endogenous Inhibitors Of Angiogenesis; In Vivo Animal Studies; P53 Tumour Suppressor Protein; Proteomics; Tumor Biology
Abstract
In order for cancers to grow and become life threatening, new blood vessels must form to deliver oxygen and nutrients to tumour cells. The process of blood vessel formation, or angiogenesis, is an absolutely necessary step in tumour formation without which they cannot grow beyond a few millimeters. Consequently, understanding the molecular machinery responsible for angiogenesis is highly critical, as it is an ideal process to target with novel therapeutic agents. The p53 tumour suppressor is a gene that becomes non-functional in half of all human cancers due to mutations. Previous research by our laboratory has found that p53 is able to inhibit angiogenesis in normal cells by causing the secretion of factors that prevent the formation of blood vessels. My project will aim to identify novel angiogenesis inhibitors activated by p53 and understand how p53 directs normal cells to release these inhibitors by dissecting the proteins and biochemical pathways involved in this process. This will lead to a better understanding of how natural angiogenesis inhibitors are produced and how their production is subverted in cancer. Furthermore, the properties of these natural angiogenesis inhibitors allow them to be translated almost directly to clinical studies, and may as such lead to the development of novel therapeutic avenues for the treatment of cancer.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Assadian, Sarah
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~